The Safety and Effects of the Beta-Blocker, Nadolol, in Mild Asthma; An Open-label Pilot Study

Beta-blockers are currently contraindicated in asthma because their acute administration may be associated with worsening bronchospasm. However, their effects and safety with their chronic administration are not well evaluated. The rationale for this pilot study was based on the paradigm shift that...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hanania, Nicola A, Singh, Supria, Eli-Wali, Rami, Flashner, Michael, Franklin, Amie E, Garner, William J, Dickey, Burton F, Parra, Sergio, Ruoss, Stephen J, Shardonofsky, Felix, O'Connor, Brian J, Page, Clive, Bond, Richard A
Médium: Artigo
Jazyk:Inglês
Vydáno: 2007
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2254137/
https://ncbi.nlm.nih.gov/pubmed/17703976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pupt.2007.07.002
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky